Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4476 - 4500 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR04
  • Cytolipin R(d18:1/22:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261575 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT04
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261591 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF04
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261671 1310.843843 C66H122N2O23
Diacylglycerophosphoinositolglycans LMGP15010105
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:0)
126457473 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010128
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/14:0)
126457496 1310.699958 C60H111O28P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA06
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261857 1309.884979 C68H127NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261625 1309.884979 C68H127NO22
Diacylglycerophosphoinositolglycans LMGP15010106
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:1(9Z))
126457474 1308.684308 C60H109O28P
Diacylglycerophosphoinositolglycans LMGP15010134
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:1(9Z)/14:0)
126457502 1308.684308 C60H109O28P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA08
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261859 1307.869329 C68H125NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261627 1307.869329 C68H125NO22
LMSL03001293
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R-octamethyl)-17-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[R],12Me[R],14Me[R],16Me[R],17OH))
126457734 1306.965477 C72H138O17S
Diacylglycerophosphoinositolglycans LMGP15010107
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:2(9Z,12Z))
126457475 1306.668658 C60H107O28P
Diacylglycerophosphoinositolglycans LMGP15010140
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:2(9Z,12Z)/14:0)
126457508 1306.668658 C60H107O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL05
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260256 1297.848594 C66H123NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO05
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260280 1297.848594 C66H123NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD05
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261656 1297.848594 C66H123NO23
Diacylglycerophosphoinositolglycans LMGP15010099
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:0)
126457467 1296.684308 C59H109O28P
Diacylglycerophosphoinositolglycans LMGP15010110
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/14:0)
126457478 1296.684308 C59H109O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL07
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260258 1295.832944 C66H121NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO07
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260282 1295.832944 C66H121NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD07
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261658 1295.832944 C66H121NO23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN02
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260589 1295.807792 C64H117N3O23
Diacylglycerophosphoinositolglycans LMGP15010100
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/16:1(9Z))
126457468 1294.668658 C59H107O28P
Diacylglycerophosphoinositolglycans LMGP15010116
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/14:0)
126457484 1294.668658 C59H107O28P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024